Brief: Aileron Therapeutics Files Prospectus For Resale Of Up To 7.1 Million Shares By Selling Stockholders - SEC Filing
29/01/2024 22:01
Jan 29 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* AILERON THERAPEUTICS FILES PROSPECTUS FOR RESALE FROM TIME
TO
TIME OF UP TO 7.1 MILLION SHARES OF COMMON STOCK OF CO. BY
SELLING STOCKHOLDERS - SEC FILING
Source text for Eikon: ID:n0001193125-24-018105
Further company coverage: ALRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering